Wandercraft logo

Wandercraft

Wandercraft is a Paris, France, maker of self-balancing exoskeletons, Atalante X for rehabilitation clinics and Eve for personal use, which bought Ekso Bionics on October 1, 2026. It also builds the Calvin humanoid robot for factories.2,3

Robotics Reviewed Editorial TeamUpdated November 2, 2026wandercraft.eu

Our take

Wandercraft makes the only exoskeletons we know of that balance themselves, so patients walk hands-free without crutches. In 2019 Atalante became the first self-balancing walking exoskeleton to earn a CE mark, and in September 2026 the company launched Eve for personal use.2,1

Buying Ekso Bionics on October 1, 2026 created what the company calls the world's leading medical exoskeleton company, with Atalante X and EksoNR in more than 700 rehabilitation centers. The price was not disclosed, and the combined company now has two personal exoskeletons and a humanoid program competing for attention.3,4

Scores by criterion

Wandercraft scores out of 10
Pricing transparency4.0
Product maturity7.0
Deployment evidence6.5
Company durability6.0
Ease of integration6.0
Overall score (average of the five)5.9

Each criterion is defined on our methodology page.

Who uses Wandercraft and what it's for

Rehabilitation centers buy Atalante X and EksoNR for gait training. Between them the two platforms hold FDA clearances and CE marks covering stroke, spinal cord injury, multiple sclerosis, and acquired brain injury.3

Eve and Ekso's Indego Personal serve eligible people with spinal cord injuries at home. Wandercraft says Medicare covers qualifying exoskeletons under its brace benefit category for patients who meet eligibility and medical necessity criteria.4,5

Atalante X, Eve, and Calvin

Wandercraft was founded in Paris in 2012 by Nicolas Simon, Matthieu Masselin, and Jean-Louis Constanza. Atalante was cleared by the FDA for stroke rehabilitation, which opened US clinics, and its technology is used at more than 150 clinical and research sites.2

The same self-balancing technology drives Calvin, a humanoid robot for heavy, repetitive industrial work. Renault Group took a stake and became an industrial partner alongside a Series D round.2,6

The Ekso Bionics deal

Wandercraft bought Ekso Bionics from a subsidiary of ChronoScale Holdings, and the deal was signed and closed at the same time. Financial terms were not disclosed.3

Chief executive Matthieu Masselin told IZON the combined company can produce up to 2,000 units a year at its Paris facility and now has manufacturing in France and the US.4

Competitive landscape

Which of these companies scores best, and who is each one built for?Hover over or tap a logo for details.
Top rated, for patients and clinicsTop rated, for large hospitalsLower score, for patients and clinicsLower score, for large hospitals45678910Review Score← Patients and clinicsLarge hospital systems →Who it's built for5.96.37.06.65.8
Wandercraft and its competitors
CompanyProductPricing modelDeployment footprintWhere Wandercraft wins or loses
WandercraftAtalante X and Eve self-balancing exoskeletons1Not published1Devices in more than 700 rehabilitation centers after buying Ekso4Self-balancing walking; prices not published
LifewardReWalk personal exoskeleton and AlterG anti-gravity systems12Medicare fee of $91,032 for a personal exoskeleton11Individual users through Medicare and insurers; AlterG in more than 4,000 facilities11Lifeward wins on Medicare pricing history for personal exoskeletons. Wandercraft wins on self-balancing, hands-free walking.
MyomoMyoPro powered arm and hand brace23Medicare fee schedule rates of $33,481 and $65,87214Patients reached through clinician referrals and orthotics and prosthetics channels15,24Myomo wins for arm and hand weakness. Wandercraft wins for people who need help to stand and walk.
CyberdyneMedical HAL wearable robot controlled by the wearer's bio-electric signals16Not published; listed for business buyers25Cleared in the EU, the US, and markets in APAC and the Middle East16Cyberdyne wins on control by the wearer's own signals. Wandercraft wins on hands-free, self-balancing walking.
HocomaLokomat robotic gait trainer26Not published26Rehabilitation hospitals and clinics; more than 550 published studies26Hocoma wins on a long research record for robotic gait training. Wandercraft wins on overground walking and a personal device.

Limits

Wandercraft publishes no device prices, so clinics and individuals need a quote and, for personal use, an insurance decision.5

Integrating Ekso while launching Eve and building a humanoid stretches a company that was much smaller than its new footprint.4,2

Revenue is not disclosed. We estimate the combined company at $15 million to $25 million a year, based on Ekso Bionics' 2025 revenue of $12.8 million and Wandercraft's own sales before the deal. This is an estimate, not a reported figure.7,6

What customers say

Where it helps

Atalante X and EksoNR have years of clinical use behind them, and Wandercraft says its technology has taken more than 25 million real-world steps.1,3

Paris 2024 gave the company a public showcase: its exoskeletons carried the Olympic and Paralympic torches, including for Thibault Simon, whose brother co-founded Wandercraft.2

Where it falls short

We found no independent buyer reviews comparing Atalante X with other gait trainers on cost. Clinics should ask for utilization data from similar centers before buying.2

Leadership

  • Matthieu Masselin

    Matthieu Masselin

    Founder and CEO

    Masselin co-founded Wandercraft in Paris in 2012 and led its October 2026 acquisition of Ekso Bionics.2,4

    Read full profile

  • Nicolas Simon

    Nicolas Simon

    Founder, AI and controls

    Simon watched a robot learn to walk in a university robotics club and thought of his brother, who was losing the ability to walk.2

  • Jean-Louis Constanza

    Jean-Louis Constanza

    Founder, humanoids business development

    Constanza co-founded Wandercraft and now works on business development for its Calvin humanoid robots.2

Sources

  1. Wandercraft, Homepage, accessed November 2, 2026
  2. Wandercraft, About us, accessed November 2, 2026
  3. Wandercraft, Wandercraft acquires Ekso Bionics, October 1, 2026, accessed November 2, 2026
  4. IZON, Wandercraft acquires Ekso Bionics to form major exoskeleton player, accessed November 2, 2026
  5. MedDevice Startups, Wandercraft buys Ekso Bionics and puts four medical exoskeletons under one owner, accessed November 2, 2026
  6. GlobeNewswire, Wandercraft announces Series D round, bringing $75M in total funding, June 11, 2025, accessed November 2, 2026
  7. SEC, Ekso Bionics 2025 annual report, revenue note, accessed November 2, 2026
  8. Wandercraft, Atalante X, accessed November 1, 2026
  9. Wandercraft, Eve personal exoskeleton, accessed November 1, 2026
  10. Wandercraft, Wandercraft acquires Ekso Bionics, accessed November 1, 2026
  11. Lifeward, Form 10-Q for the quarter ended September 30, 2024, accessed November 1, 2026
  12. Lifeward, Fourth quarter and full year 2025 financial results, accessed November 1, 2026
  13. Myomo, About Myomo, accessed November 1, 2026
  14. Myomo, CMS posts final Medicare DMEPOS fee schedule rate for the MyoPro, March 1, 2024, accessed October 31, 2026
  15. Myomo, Second quarter 2026 results, SEC exhibit 99.1, August 5, 2026, accessed October 31, 2026
  16. Cyberdyne, Medical HAL lower limb type, accessed November 2, 2026
  17. Cyberdyne, Financial results briefing for the fiscal year ended March 31, 2026, May 14, 2026, accessed November 3, 2026
  18. Cyberdyne, Consolidated financial results for the fiscal year ended March 31, 2026, May 14, 2026, accessed November 3, 2026
  19. DIH Holding US, Form 10-K for fiscal year ended March 31, 2025, accessed November 9, 2026
  20. DIH, Hocoma, accessed November 9, 2026
  21. Springer, Lokomat cost study, accessed November 9, 2026
  22. Moneyhouse, Hocoma AG, accessed November 9, 2026
  23. Myomo, Homepage, accessed October 31, 2026
  24. Myomo, Fourth quarter and full year 2025 results, accessed October 31, 2026
  25. Cyberdyne, Products and services, accessed November 2, 2026
  26. Hocoma, Lokomat, accessed November 2, 2026